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Abstract
The extent of the endocortical region and cortical bone mineral density (cBMD) throughout the proximal femur are
of interest as both have been linked to fracture risk and osteoporosis treatment response. Non-invasive in-vivo clinical
CT-based techniques capable of measuring the cortical bone attributes of thickness, density and mass over a bone surface
have already been proposed. Several studies have robustly shown these methods to be capable of producing cortical
thickness measurements to a sub-millimetre accuracy. Unfortunately, these methods are unable to provide high quality
cBMD estimates, and are not designed to measure any attributes over the endocortical region of cortical bone. In this
paper, we develop a cortical bone mapping based technique capable of providing an improved cBMD estimate and a
measure of the endocortical width, while maintaining similar quality cortical thickness and trabecular bone mineral
density (tBMD) estimates. The performance of the technique was assessed using a paired dataset of ex-vivo QCT and
HR-pQCT scans across 72 proximal femurs. The HR-pQCT scans were analysed using a new method developed for this
study: high resolution tissue classification (HRTC). In HRTC the cortical, endocortical and sub-surface trabecular bone
features are extracted from the partially resolvable microarchitectural details in the HR-pQCT scan. We demonstrate
that measurement of the endocortical extent from QCT is possible with an accuracy of −0.15± 0.71 mm, and that local
cBMD can be measured down to densities of 300 mg/cm
3
.
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1. Introduction
Fragility fractures due to osteoporosis and other skele-
tal diseases are a significant public health burden (Kanis
et al., 2013; World Health Organisation, 2007), which is
set to increase as the global population continues to age.5
The societal cost of hip fractures is particularly severe due
to high morbidity and mortality associated with this frac-
ture (World Health Organisation, 2007). The quantity and
severity of fragility fractures can be reduced through early
identification and treatment of those at risk. Fracture risk10
prediction, treatment assessment and the monitoring of
osteoporosis disease progression in the proximal femur are
hence all of particular interest.
In current clinical practice, areal bone mineral den-
sity (aBMD), a two dimensional measure of bone mineral15
density extracted from Dual-energy X-ray Absorptiometry
(DXA) scans, is used to assess fracture risk and treatment
effectiveness (World Health Organisation, 2007). Despite
widespread use, DXA scans are not capable of directly
measuring three dimensional features of bone (Ohnaru et al.,20
2013) or focal variations in bone structure, both of which
have been linked to fracture risk (Holzer et al., 2009; Poole
et al., 2012; Verhulp et al., 2008). Thus a three dimen-
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sional imaging modality combined with a technique capa-
ble of preserving and extracting these features is desirable.25
As most mineralised bone is either cortical or subsurface
trabecular bone, this is the region of particular interest for
modelling (Yang et al., 2012).
Quantitative Clinical CT (QCT) scans provide such a
three dimensional measure of BMD but have limited res-30
olution. Much of the cortex is a thin structure well below
this resolution, and its measurement is challenging. Sev-
eral techniques exist for measuring cortical and subsurface
trabecular features from QCT (Hangartner and Gilsanz,
1996; Hangartner and Short, 2007; Streekstra et al., 2007;35
Treece et al., 2010). These techniques, however, are only
marginally more effective than aBMD-based methods at
fracture risk prediction and treatment assessment (Poole
et al., 2012; Treece et al., 2015; Yang et al., 2012). Cur-
rently, the most accurate are model-based techniques. These40
use a transect of cortical and subsurface trabecular bone
sampled from the QCT scan, a parametrised estimate of
the underlying density, and an estimation of the imaging
blur, to model the underlying cortical features using de-
convolution.45
Cortical Bone mapping (CBM) is one of these model-
based techniques. Many local measurements are made
over the surface of the bone and combined to provide
surface maps of the measured features. This allows fo-
cal regional variations between populations to be detected.50
Previous implementations used a simple three tier model
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to represent the density in profile across the cortex at
each surface location (Treece and Gee, 2015; Treece et al.,
2010, 2012). This three tier model is only capable of mea-
suring the cortical thickness, the cortical bone mineral55
density (cBMD) and the trabecular bone mineral den-
sity (tBMD), where these measurements are single ag-
gregate values across the entire cortical or trabecular re-
gion included in the profile. These values can be used
to calculate the mass surface density (MSD), which is60
the mass of mineralised cortical bone per unit area over
the periosteal surface (Treece et al., 2012). MSD is more
resistant to errors resulting from the limited resolution
of QCT (Treece et al., 2012). However, the CBM model
does not measure the endocortical region, which exists be-65
tween the compact cortical bone and the porous trabec-
ular bone (Ma, 2014). It has been suggested that this is
a region of elevated remodelling in later life (Seeman and
Delmas, 2006; Zebaze et al., 2013). As such, it may pro-
vide an early indication of deteriorating bone quality, and70
a measure of targeted regeneration caused by therapies for
the treatment of osteoporosis.
The initial implementation of CBM used a single fixed
cBMD value applied over the measurement surface: this
increased the stability and precision of the technique (Treece75
et al., 2010, 2012). In addition to not providing any local
cBMD measurement, it also limited the accuracy of the
model at any location where the cortical density varied
from the global estimate, and increased the bias of corti-
cal thickness for thin structures (Treece and Gee, 2015).80
For these reasons, a two phase model-based fitting tech-
nique termed CBMv2, aimed at relaxing the rigidity of the
cBMD constraint, was proposed (Treece and Gee, 2015).
Although this technique enabled local cBMD measure-
ments, while improving the overall stability of the method85
and improving the quality of the cortical thickness mea-
surements, the quality of the cBMD measurements re-
mained poor (Treece and Gee, 2015).
cBMD is affected by both the degree of mineralisation
of bone (DMB) and porosity of cortical bone (Augat and90
Schorlemmer, 2006; Boivin et al., 2008; Follet et al., 2004;
McCalden et al., 1993). The DMB is an intrinsic mate-
rial property of bone tissue, while porosity is a property of
the microarchitecture of bone. cBMD increases with DMB
but decreases with porosity, while fracture risk decreases95
with DMB and increases with porosity. Hence a decrease
in cBMD due to either mechanism increases fracture risk.
The relative contributions of each to cBMD cannot be dis-
tinguished at the comparatively low resolution of QCT.
Instead it is only possible to measure the average cBMD,100
which is still a significant indicator of bone strength and
fracture risk (Augat and Schorlemmer, 2006; Follet et al.,
2004; McCalden et al., 1993).
The aim of this work is to extend the CBM technique
to both measure the thickness of the endocortical region105
for the first time from QCT scans, and to more accurately
measure the cBMD. In Section 2 the current CBM tech-
nique is detailed before a more representative model of the
cortical and subsurface trabecular region, and a new vari-
able cBMD fitting scheme, are introduced. In Section 3110
the quality of the endocortical thickness and cBMD mea-
sures are assessed, against equivalent measures extracted
from HR-pQCT scans, using a dataset of paired QCT and
HR-pQCT scans. In Section 4 the ability of the new model
and fitting scheme to measure the cortical and subsurface115
structure of bone is examined. Conclusions on the suit-
ability of the proposed model and fitting scheme are then
drawn in Section 5.
2. Methods
2.1. Constrained three-tier rectangle model120
CBM is a pipeline-based technique, as shown in Fig-
ure 1, in which many features are measured at different
locations over a surface and combined into surface maps
of each feature. Each set of feature measurements is ex-
tracted from a parametrised model that describes the den-125
sity variation along a transect through cortical and sub-
surface trabecular bone at a particular surface location.
Previous work has used the three-tier rectangle model,
termed the ‘rectangle model’ throughout the remainder
of this paper, shown in Figure 2A. The model has in-130
stantaneous transitions between the different tissues and
a constant density over the entire cortical cross-section. It
is also constrained at each surface location to share the
same globally fixed cBMD value. The remaining model
features and the image point spread function (PSF) are135
then varied, until the resulting density profile estimate
best matches the density profile sampled from the image.
This is achieved with the Levenberg-Marquardt optimisa-
tion method (LMM) as discussed in Section 2.3. The re-
sulting models can be used to generate cortical thickness140
and tBMD surface maps.
A key component of this algorithm is the convolution
of the density model with the image PSF, which is pre-
sumed to be Gaussian, to produce the density profile es-
timate. Convolution is an O (N2) operation. This can be145
reduced to an order O (N) integration by first differenti-
ating Eqn 1a and then applying the ‘Sifting’ property of
the subsequent Dirac Delta functions as shown in Eqn 1c
(Treece et al., 2012), where yst, ycb, ytb, xP , xE and σ re-
spectively correspond to the density of soft tissue, the den-150
sity of cortical bone, the density of trabecular bone, the
location of the cortex periosteal edge, the location of the
cortex endosteal edge, and the standard deviation of the
Gaussian PSF. H(x) represents the unit step function, and
erf() is the error function that results from integrating a155
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Figure 1: The Cortical Bone Mapping Pipeline.
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The model-fitting problem is ill-posed due to the large
number of model parameters relative to the information
available in the blurred density profile. This is the reason
for using the simple rectangle model, and constraining the160
cortical density to reduce the number of unconstrained pa-
rameters to five. The recently proposed CBMv2 method
relaxes the rigidity of the cBMD constraint by perform-
ing two CBM measurement steps: the first with the global
cBMD constraint, and the second with a locally adjusted165
cBMD constraint based upon the difference between the
local blur estimate from the initial CBM measurement and
a global estimate of the PSF blur (Treece and Gee, 2015).
This allows for some variability in the cBMD, while main-
taining the number of unconstrained parameters at five.170
2.2. Endocortical region model
The endocortical region is the interface between the
cortical and trabecular bone. It is of particular interest
as it has been suggested that this is the primary site of
remodelling in later life, when most fragility fractures oc-175
cur (Seeman and Delmas, 2006; Zebaze et al., 2013). The
increased endocortical remodelling has been linked to a de-
crease in the DMB and also an increase in porosity (Boivin
et al., 2008; Follet et al., 2004; Zebaze et al., 2013), both
of which result in decreased BMD over the endocortical180
region. We model this by adapting the rectangular model
to include a finite width linear transition from ‘dense’ cor-
tical bone to trabecular bone as shown in Figure 2B. This
new model is called the ‘endocortical model’ throughout
the rest of this paper.185
Having effectively split the location of the endosteal
edge in two, we can measure the ‘dense’ cBMD (dBMD),
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Figure 2: The parametrised bone surface density models. (A) The
rectangle model. (B) The endocortical region model.
the dense cortical bone thickness, the width of the endo-
cortical region and tBMD. These may also be combined to
derive measures of the cortical bone thickness thcb and190
cBMD. Eqn 2 is used to calculate these measurements
by assuming the cortical bone region extends half-way
through the endocortical region. In this and the following
Eqn 3 the meaning of yst, ytb, xP , and σ remain unchanged
compared to Eqn 1a, while ydb replaces the ycb of the rect-195
angle model and corresponds to dBMD. xEcb and xEtb cor-
respond to the location of the beginning and end of the
endocortical region.
thcb = (xEcb − xP ) + 12 (xEtb − xEcb) (2a)
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Once again, it is desirable to avoid performing anO (N2)
convolution at each step in the optimisation process. The200
presence in the model of R(x), the Ramp function, re-
quires an additional integration-differentiation step before
the ‘Sifting’ property can be applied to the resulting Dirac
Delta functions, producing the more complex result in
Eqn 3. The required integral of the error function is not205
supported in standard libraries, however it can be precom-
puted and accessed at runtime using a look-up table.
3
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The LMM is also used to fit the endocortical model.
As with the constrained rectangle model, the dBMD value
can be fixed before performing CBM to increase the stabil-210
ity of the optimiser. However, without any other changes
to the overall CBM process, the stability will be lower
than the rectangle CBMv2 method, due to the inclusion
of the additional endocortical width parameter that fur-
ther destabilises the already ill-posed problem. This can215
be counteracted, to some extent, through the careful man-
agement of the optimisation process.
2.3. CBM optimisation
In the CBM method an optimiser is used to select those
model parameters which give the best possible alignment220
with the sampled image densities. This is a non-linear
least-squares problem, in which the squared error between
the sampled image density and the blurred parametrised
model is minimised, by iterative improvement of an initial
guess, using the LMM (More´, 1978). Crucial to this pro-225
cess is a problem-specific cost function which, when pro-
vided with the model parameters, updates an error vector
containing differences between the modelled and sampled
densities, as well as some other constraints relating to the
physical validity of the model. It is this error vector which230
is minimised by the LMM.
2.3.1. Validity of model parameters
A density model is physically invalid if it has a nega-
tive cortical thickness, a cBMD less than the tBMD, or a
negative or extremely large Gaussian blur. The endocor-235
tical model is also invalid if it has a negative endocortical
thickness. The error vector includes an element for each
possible physically unrealistic trait; Eqn 4 is used to de-
fine the error associated with each such trait.  is the error
reported in the error vector; k is the scaling factor associ-240
ated with that trait; t is the model trait; and tminimum is
the model trait value below which the model is physically
invalid. The error value approaches 0 for valid traits, and
exponentially increases with the magnitude of an invalid
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Figure 3: The different weighting functions used when calculating
the cost function error vector during each optimisation stage in the
CBM methods.
trait. k is chosen to produce similar magnitude errors from245
each model trait.
 = ek·(t−tminimum) (4)
2.3.2. Optimiser weighting function
The error vector also includes an element for the signed
difference between each sampled density value and the
blurred model. These error values are scaled by a weight-250
ing function, which was used in previous implementations
of the CBM method to encourage the optimiser to converge
on a model that was closely aligned to the underlying pe-
riosteal surface and hence improve the model fit (Treece et al., 2010, 2012; Treece and Gee, 2015).
As such, the weighting function controls the relative im-255
portance assigned to discrepancies between the blurred
model and the sampled image density along the profile,
with a tighter fit expected over portions of the profile as-
signed a higher relative weight. This means that the shape
of the weighting function can be used to improve the qual-260
ity of specific model traits, which has lead to the use of
several different weighting functions as shown in Figure 3.
The rectangular CBMv2 method uses the ‘CBMv2 rect-
angle model’ weighting function, whose peak is aligned
with the initial estimate of the periosteal edge, i.e. the loca-265
tion of the initial surface segmentation. As previously de-
scribed, in the first LMM optimisation, all other model val-
ues are initialised to the same generic constants for all loca-
tions. The results of this optimisation are used to initialise
the second LMM, having re-aligned the weighting func-270
tion to the updated periosteal edge estimate. The third
LMM optimisation then makes use of the new cBMD con-
straint, adjusted based upon the image blur. The remain-
ing weighting functions included in Figure 3 are used in the
optimisation of the endocortical model by the Smoothly275
spatially constrained CBM (SSC-CBM) method described
in Section 2.4. Note that the repeated optimisation runs
are very fast, since the initial model parameters are usually
very close to the converged solution.
2.4. Smoothly spatially constrained CBM (SSC-CBM)280
The reduced stability of the endocortical model com-
pared to the rectangle model can be combated by improv-
4
ing the quality of the dBMD estimate used to constrain the
endocortical model and by appropriately penalising phys-
ically invalid models. Improved dBMD measurements are285
also clinically desirable as dBMD is linked to bone strength
and fracture risk (Augat and Schorlemmer, 2006; Follet
et al., 2004; McCalden et al., 1993). The pipeline shown in
Figure 4 was developed to provide improved dBMD esti-
mates. Its design was based on the surface mapped dBMD290
values observed in the proximal femur of HR-pQCT scans.
The pipeline contains two endocortical CBM measure-
ment steps. The first is a partially constrained CBM
method that is used to produce dBMD estimates with
three LMM optimisations of which the first two use the295
rectangle model to improve stability. The first LMM uses
a generically initialised and dBMD-constrained rectangle
model. These model parameters are used to initialise the
second LMM, which is still constrained by the generic
dBMD value but with an aligned weighting function. The300
resulting parameters initialise the final LMM, which is an
entirely unconstrained endocortical model with a generic
endocortical thickness. This partially constrained con-
figuration has greater stability than using a fully uncon-
strained optimisation (Pakdel et al., 2012). The resulting305
dBMD surface map is noisy, so it was spatially smoothed
using Gaussian distance-weighted precision smoothing. The
σ of the Gaussian distance filter was specified globally at
6 mm, while the precision value was calculated locally from
estimates of the variance of the LMM model parameters.310
These smoothed locally-varying dBMD values were used
as constraints in the second CBM measurement step.
The endocortical SSC-CBM method uses the ‘unaligned’
and ‘aligned’ weighting function, shown in Figure 3. The
‘unaligned rectangle model’ is used with generically ini-315
tialised rectangle models to produce periosteal alignment
of the model. The ‘aligned rectangle model’ weighting
function is used with rectangle models that have been ini-
tialised with the results from a previous LMM optimisa-
tion. The initial cortical thickness value is used to define320
the width of the uniformly weighted region of the weighting
function. The ‘aligned endocortical model’ weighting func-
tion is similarly used with endocortical models initialised
with the results from a previous LMM optimisation.
3. Experiments and results325
3.1. Data acquisition
The quality of the measurements produced with the
proposed methods was assessed using direct comparison
between QCT and HR-pQCT scans from an ethically ap-
proved study of cadaveric proximal femurs. This is the330
same dataset used in the initial assessment of the CBMv2
method (Treece and Gee, 2015). The left and right femurs
of 18 females and 17 males were stripped of soft tissue,
submerged in a saline solution, then vacuum packed to
remove air bubbles, and scanned. The mean age of the in-335
dividuals was 77 years (range 59-96 years). The QCT data
was acquired using a Brilliance641 scanner at 120 kV with
a pixel sizing of 0.33×0.33×1 mm3. The Hounsfield Units
were converted to density using a QRM-BDC calibration
phantom2 scanned with each specimen.340
The reference HR-pQCT data was captured using an
XTremeCT3 scanner at 70 kV with a pixel sizing of 0.082×
0.082×0.082 mm3. The HR-pQCT images were converted
to density using a linear calibration curve provided by
the manufacturer combined with a quadratic correction345
for non-linearities in the HU to BMD relationship as de-
tailed in Appendix A. This gave a total of 74 paired high
and low-resolution data sets from 37 patients. Two scan
pairs were excluded, one for high levels of ring artefact in
the HR-pQCT scan, and one for a HR-pQCT scan imaged350
with a restricted field of view. Further details of this study
have been published previously (Dall’Ara et al., 2013a,b).
3.2. High resolution tissue classifier (HRTC)
HR-pQCT scans were used to produce ‘gold standard’
measurements for direct comparison with the results of the355
newly proposed CBM scheme. This was achieved with a
new technique called the High Resolution Tissue Classi-
fier (HRTC), which produces localised cortical thickness,
endocortical thickness, cBMD and tBMD measurements
over a periosteal surface. The HRTC technique was de-360
veloped as no previously published techniques provide lo-
calised measurements of both the dense cortical, endocor-
tical and trabecular regions (Burghardt et al., 2010; Hilde-
brand and Ru¨egsegger, 1997; Laib et al., 1997; Liu et al.,
2010; Treece et al., 2010, 2012; Zebaze et al., 2014). How-365
ever, measurements from the HRTC method are defined
in-line with equivalent aspects from other published HR-
pQCT methods. HRTC has four stages as shown in Fig-
ure 5: sampling, thresholding, sectioning, and modelling
of the different regions.370
The HRTC uses many closely sampled parallel profiles
to discriminate between microstructure features and the
cortical and subsurface trabecular macrostructure features
that are actually of interest here. The profiles are sampled
over a uniform grid at the pixel resolution within a fixed375
radius centred about each surface measurement location.
The density samples along each profile are then thresh-
olded as either ‘bone’ or ‘not bone’ in the thresholding
step in Figure 5. The thresholds used were selected to
be the mean of non-ossified and fully mineralised tissue380
densities in each scan. This allows the percentage of the
profiles passing through bone at each sample location to
be recorded, revealing the cross-sectional tissue structure
at each sample location along the profile. The percent-
age profile is used in the sectioning step of Figure 5 as385
this provides a more reliable measure of the cross sectional
structure than either a single density profile as illustrated
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Figure 4: The Smooth spatially constrained CBM pipeline.
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Figure 5: The four stages of the High Resolution Tissue Classifier method: sampling parallel profiles at the image resolution; thresholding
each density sample into ossified or non-ossified tissue; sectioning the bone percentage profile to define the extents of the different tissues
along its length; and modelling the density of each tissue type.
in Figure 6, or the mean cross-sectional density, which is
affected by the DMB of each profile in addition to the pro-
portion of profiles passing though ossified and non-ossified390
tissue. The HR-pQCT scans were processed with paral-
lel profiles sampled over a radius of 0.7 mm to match the
QCT resolution as estimated based on the blur measured
by the rectangular CBMv2 method. This gave a total of
225 parallel profiles at each measurement location.395
The bone percentage is used to classify the profiles into
four different regions: cortical bone, dense cortical bone,
the endocortical region and trabecular bone. These regions
were selected to allow the quality of both the rectangle and
endocortical models to be assessed. Figure 5 shows the400
cortical, endocortical and trabecular regions: the dense
cortical bone region lies between the start of the cortical
bone and the start of the endocortical region. The corti-
cal bone region extends from the first point where half the
maximum percentage along the profile (%max) is reached,405
to the first point the percentage falls below the average of
the %max and the mean trabecular percentage (%t¯b). This
aims to represent the same region that is measured by the
full-width half-max method used to validate previous im-
plementations of the CBM method (Treece and Gee, 2015;410
Treece et al., 2010, 2012). The dense cortical bone region
is the portion of the cortical bone before the first endo-
cortical pore: defined as the point where the percentage
array last falls below %max, in line with previous meth-
ods (Zebaze et al., 2013). The endocortical region extends415
from the first endocortical pore in the cortical bone region
to the first minimum after the percentage array drops to
%t¯b, and the trabecular region extends from the end of the
endocortical region to the end of the profile.
3.3. Experimental pipeline420
Figure 7 shows the pipeline used to evaluate the qual-
ity of the endocortical SSC-CBM method against both the
HRTC validation method, and the previous ‘best’ imple-
mentation of the CBM: the rectangular CBMv2 method.
First, a single canonical surface was used to segment each425
scan, as this allows for direct comparison between the mea-
surements made on each paired set of QCT and HRpQCT
scans, and between scans of different individuals. The
canonical surface was registered to a manually segmented
surface in each QCT scan using a locally affine free-form430
deformation calculated by an iterative closest point point
registration algorithm (Feldmar and Ayache, 1996). A sim-
ilarity registration was then applied between the regis-
tered QCT surface and a manually segmented surface in
each matching HRpQCT scan. The rectangular CBMv2435
and the endocortical SSC-CBM methods were applied to
the QCT scans, while the HRTC validation technique was
applied to the HRpQCT scans. Two iterations of mesh
connectivity-based precision-weighted smoothing were per-
formed over the CBM measurements, which were matched440
with two iterations of evenly weighted smoothing over the
HRTC measurements. The CBM precisions were extracted
from the estimated model parameter variances of the fi-
nal LMM optimisation at each measurement site. The
smoothing was performed to remove outlier measurements445
with very low precision optimisations. Figure 7 shows
a representative example of the models produced by the
endocortical SSC-CBM and HRTC methods at the same
measurement location.
3.4. Results450
The canonical surface contains 5580 measurement loca-
tions resulting in more than 400000 measurements across
the 72 scans in the validation dataset. The quality of the
6
iii
i
ii
A B C
Soft Tissue
Mineralised Bone
Non-Ossified space
Bone
Bone
Bone
Bone
Figure 6: A two dimensional representation of the three dimensional bone microstructure and parallel profile sampling. (A) The microstructure
of cortical and sub-surface trabecular bone. (B) Two sampled profiles; profile ii passes through substantially more bone than profile i despite
the similar microstructure around each profile. (C) Two parallel sampled profiles, which produce much more similar aggregate density profiles.
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Figure 7: The pipeline used to evaluate the effectiveness of the proposed endocortical SSC-CBM implementation against both the CBMv2
method and HR-pQCT based HRTC method. (A) The registration and model fitting applied to each QCT and HR-pQCT scan pair. (B)
The comparisons made between the methods.
cortical, dense cortical, endocortical and trabecular region
measures produced by the two CBM methods were as-455
sessed against each other, and the HRTC validation mea-
surements. Table 1 shows the measurement bias and preci-
sion for both CBM methods, while Figures 9-11 show con-
fidence interval (CI) plots of CBM measurements against
the corresponding HRTC measurements. These are used460
to compare the physical features measured by the HRTC
and CBM methods.
The bias and precision values recorded in Table 1 are
defined through comparison with the equivalent HRTC
measurements, and as in previous publications (Treece465
and Gee, 2015; Treece et al., 2010, 2012) these values are
calculated over three different cortical thickness ranges:
0.3−1mm, 1−3mm, and 3−6mm. The table also records
the overall stability, defined as the percentage of success-
fully fit models out of the total number of measurement470
locations for each method. The CI plots show the median-
based bias and the percentile-based precision at each HRTC
value in combination with the frequency distribution of the
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Figure 8: HR-pQCT (Top) and QCT (Bottom) profile pair with inwardly increasing intracortical porosity; the endocortical width is accurately
measured.
HRTC values. Figure 9 shows the CI plots for the rect-
angular CBMv2 method, while Figures 10 and 11 display475
the CI plots for the endocortical SSC-CBM method.
The rectangle model lacks any measure of the dense
cortical and endocortical regions, so the bias and preci-
sion values relating to these regions are omitted from the
table. The cortical thickness and cBMD of the endocor-480
tical model were measured indirectly using Eqn 2. All
other regions were directly measured from the endocorti-
cal model. The surface density for each method was also
calculated across each thickness range as defined in pre-
vious work (Treece and Gee, 2015; Treece et al., 2012)485
and included in Table 1. The cortical thickness, cBMD,
tBMD and surface density CI plots for both methods are
included in Figures 9 and 10, while the additional dense
cortical thickness, dBMD and endocortical width measure-
ments of the endocortical SSC-CBM method are displayed490
in Figure 11.
4. Discussion
The values reported in Table 1 and Figures 9-11 show
that the endocortical SSC-CBM method is able to mea-
sure the thickness of the endocortical region, while broadly495
maintaining the quality of the cortical thickness, tBMD
and MSD measurements from the CBMv2 method. The
endocortical SSC-CBM method can measure endocortical
thickness with an overall accuracy of −0.15± 0.71 mm.
The CI plots and accuracies reported in Table 1 show that500
the endocortical thickness measurements are accurate over
the range of 1− 6 mm, but the thicknesses are underesti-
mated for values less than 1 mm. In addition, the endocor-
tical thickness precisions are lower than the cortical thick-
ness measurements made by both CBM methods. Despite505
this, the overall quality of the endocortical thickness mea-
surements is notable in comparison to the cortical thick-
ness measurements of previously validated CBM meth-
ods (Treece and Gee, 2015; Treece et al., 2012, 2010) that
were used to detect statistically significant focal changes510
in cortical thickness in response to osteoporosis treatment
therapies (Allison et al., 2015; Poole et al., 2015; Whitmarsh et al., 2015, 2014, 2016),
and across populations with differing fracture risk pro-
files (Poole et al., 2016; Treece et al., 2015).
The rectangular CBMv2 and endocortical SSC-CBM515
methods both relax the single fixed density constraint ap-
plied to the model during CBM. The quality of the re-
sulting density constraint directly affects the quality of
the resulting models. Unfortunately, the constraint maps
cannot be directly compared as one is of cBMD measures520
and the other is of dBMD measures. Instead, the cBMD
values derived from the SSC-CBM endocortical model us-
ing Eqn 2b can be compared with the cBMD constraint
applied to the rectangular CBMv2 model. As shown in
Table 1 and Figures 9a and 10a, both methods substan-525
tially overestimate the cBMD. Despite this, the quality
of the SSC-CBM cBMD measurement is improved with a
visibly more linear relationship and an overall accuracy of
172± 149 mg/cm3, compared with 249± 164 mg/cm3 for
rectangular CBMv2 method.530
Eqn 2 is used to derive cortical thickness and cBMD
measurements from the endocortical model. It assumes
the cortical bone extends halfway along the endocorti-
cal region: it is worth considering the validity of this as-
sumption. This is investigated in Figure 12, where Eqn 2535
and the dense cortical and endocortical HRTC measure-
ments were used to calculate derived HRTC cBMD and
cortical thickness measurements; these are plotted against
the measured HRTC cortical bone measurements. This
shows the relationships assumed in Eqn 2 result in a slight540
but consistent overestimation of cBMD and cortical thick-
ness. This does not match the overall errors in the cortical
measurements, which are also impacted by the system-
atic over- and under-estimations in the dBMD and dense
cortical thickness measurements shown in Figure 11. A545
closer inspection of these CI plots show that the endocor-
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Figure 9: CI validation plots comparing the results of the rectangular CBMv2 method against the HRTC method.
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Figure 10: CI validation plots comparing the results of the endocortical SSC-CBM method against the HRTC method.
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Figure 11: CI validation plots comparing the results of the endocortical SSC-CBM method against the HRTC method, for measurements
which were not previously possible from QCT.
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Quantity Thickness Ranges (mm)
Rectangle Endocortical
CBMv2 SSC-CBM
Stability (%) 0.0 ≤ t < 6.0 99.6 100.0
Cortical Thickness (mm) 0.3 ≤ thcb < 1.0 0.06∗±0.23∗ 0.10±0.24
1.0 ≤ thcb < 3.0 0.07∗±0.41 −0.21±0.37∗
3.0 ≤ thcb < 6.0 −0.28∗±0.60∗ −0.34±0.61
Cortical Density
(mg/cm3)
0.3 ≤ thcb < 1.0 321±153 173∗±148∗
1.0 ≤ thcb < 3.0 164∗±127∗ 208±152
3.0 ≤ thcb < 6.0 129±88∗ 118∗±121
Dense Cortical Thickness
(mm)
0.3 ≤ thcb < 1.0 - 0.08±0.14
1.0 ≤ thcb < 3.0 - −0.56±0.36
3.0 ≤ thcb < 6.0 - −0.83±0.72
Dense Cortical Density
(mg/cm3)
0.3 ≤ thcb < 1.0 - 233±154
1.0 ≤ thcb < 3.0 - 306±163
3.0 ≤ thcb < 6.0 - 170±142
Endocortical Thickness
(mm)
0.3 ≤ thcb < 1.0 - −0.47±0.43
1.0 ≤ thcb < 3.0 - 0.12±0.74
3.0 ≤ thcb < 6.0 - 0.58±0.93
Trabecular Density
(mg/cm3)
0.3 ≤ thcb < 1.0 −10∗±42 −15±42
1.0 ≤ thcb < 3.0 42±49 22∗±44∗
3.0 ≤ thcb < 6.0 80±77 17∗±58∗
Mass Surface Density
(mg/cm2)
0.3 ≤ thcb < 1.0 20.7±11.0∗ 17.2∗±12.1
1.0 ≤ thcb < 3.0 26.4±22.9∗ 12.4∗±23.4
3.0 ≤ thcb < 6.0 20.3±44.0∗ 10.1∗±44.7
Table 1: A comparison of the biases, precisions and overall stability of the two CBM methods assessed. The biases and precisions are
calculated for each physical feature measured by each CBM method. A dash is used in place of these values for features not measured by a
particular method. An ∗ is included for bias or precision values that are significantly better than the alternative method. Significance values
are calculated using a paired t-test (bias) and F-test (precision) at p < 0.001. The stability of each method is the % of successfully fit valid
models out of the set of all measurement locations where a valid HRTC model exists.
tical SSC-CBM measurements of the dense cortical region
are linearly correlated over all but the thinnest and low-
est density measurements. This is where the stability of
the optimiser is challenged most by the fundamental lack550
of information contained within the sampled density pro-
file (Treece et al., 2010).
The endocortical SSC-CBM method can hence be used
to measure the cortical thickness, cBMD, tBMD and en-
docortical extents. The definition of cortical thickness and555
tBMD measures remain unchanged from previous studies;
namely, the cortical thickness defines the width of the cor-
tical region, and the tBMD defines the average density of
the subsurface trabecular region. The cBMD value mea-
sured by the endocortical SSC-CBM method is the mean560
BMD value across the cortical region as reported by the
HRTC method. This is in contrast to previous studies
where the cBMD defined the maximum BMD value within
the cortical region (Treece and Gee, 2015; Treece et al.,
2012). The new cBMD value provides an aggregate mea-565
sure of cumulative effect of DMB and porosity on cBMD,
which should provide a better indication of fracture risk
than just the impact of DMB (Augat and Schorlemmer,
2006; Follet et al., 2004; McCalden et al., 1993). The phys-
ical meaning of the endocortical region is less well defined:570
broadly it is the distance over which the uniform pores
within compact cortical bone transition into the larger,
less uniform, marrow space of the trabecular region. Now
that the method has been validated, it needs to be used
on QCT data from clinical trials in order to ascertain the575
ability to detect statistically significant region changes in
endocortical thickness and even dBMD.
The two aligned weighting functions used in the en-
docortical SSC-CBM method were developed in response
to a systematic underestimation of cortical thickness and580
overestimation of tBMD for large cortical thicknesses. It
is believed that these errors result from a slight decrease
in BMD across the cortex due to beam hardening. The
periosteal-centred weighting functions used by the rectan-
gular CBMv2 method preferentially weight discrepancies585
between the modelled and the sampled density profile near
the periosteal edge. This can result in the optimiser over-
fitting the endosteal edge location of the model to decrease
the discrepancies in the cortex caused by beam hardening.
This may explain some of the underestimation in cortical590
thickness of the rectangular CBMv2 method that occurs
for cortical thicknesses greater than 3 mm. This effect is
largely counteracted by instead using the aligned weighting
functions in the endocortical SSC-CBM method, as illus-
trated by the fairly constant bias in the SSC-CBM cortical595
thickness measurements greater than 2 mm.
The initial validation of the rectangular CBMv2 method (Treece and Gee, 2015)
used FWHM HRpQCT measurements, rather than HRTC,
though from the same paired dataset used in this study.
The quality of the measurements reported in Table 1 and600
Figure 9 broadly agree with those reported in Treece et al.
(2015), although there are subtle differences in the cortical
thickness, cBMD and mass surface density measurements
that stem from differences between the FWHM and HRTC
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Figure 12: CI validation plots comparing direct HRTC measures of the cortical region against derived HRTC measures of the cortical region.
methods and the inclusion of two iterations of precision-605
based smoothing. The FWHM method used to validate
previous CBM methods used the same weighting function
to stabilise the optimisation process. This means its corti-
cal thickness measurements will share any errors caused by
the optimisers response to beam hardening due to unequal610
weighting along the profile. The FWHM method also
used the peak density measured over the cortical region
to define the cBMD, which is in contrast to the mean den-
sity measurement used by the HRTC method. The mean
cBMD is more clinically relevant as it incorporates the615
mean effects of both porosity and DMB, which both im-
pact bone strength (Ammann and Rizzoli, 2003; Bala et al., 2010).
5. Conclusion
The endocortical SSC-CBM method provides a model
of the cortical and subsurface trabecular region from which620
the cortical thickness, cBMD, tBMD and endocortical width
can be measured at many locations over the proximal fe-
mur. Its ability to more accurately measure the cBMD
at lower densities and to measure the endocortical width,
while still providing similar quality cortical thickness and625
tBMD measurements distinguishes it from previously pub-
lished QCT based techniques. The quality of the endocor-
tical SSC-CBM and rectangular CBMv2 methods were as-
sessed using direct comparisons between paired HR-pQCT
and QCT measurements. This necessitated the develop-630
ment of the HRTC method, a new HR-pQCT technique, as
no existing techniques were capable of providing localised
cortical thickness, cBMD, tBMD and endocortical thick-
ness measurements.
The endocortical SSC-CBM method provides sub-millimetre635
endocortical thickness measurements with accuracies of
−0.47± 0.43 mm, 0.12± 0.74 mm and 0.58± 0.93 mm over
cortical thickness ranges of 0.3−1 mm, 1−3 mm, and 3−6 mm,
and cBMD measurements down to a density of 300 mg/cm
3
,
while maintaining similar quality cortical thickness and640
MSD measurements as CBMv2. Although this investiga-
tion shows it is possible to measure the thickness of the
endocortical region from QCT resolution data, the clinical
relevance of this measurement still needs to be established.
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Appendix A. Appendices
Appendix A.1. QCT Calibration650
The QCT scans included a QRM-BCD calibration phan-
tom, which contain three cores with known densities of
0 mg/cm
3
, 100 mg/cm
3
and 200 mg/cm
3
. In each scan
each core was sampled in a central location across all slices
along its length. These values were averaged to produce655
three HU values, which were matched with their associated
density. The linear calibration coefficients for each scan
were then calculated as the linear fit between the paired
HU and density values. The individually calculated coeffi-
cients for each scan were then combined to give an average660
set of coefficients. This was only performed after the co-
efficients were viewed to ensure there were no outliers. A
representative calibration curve is shown in FigureA.13A.
Appendix A.2. HRpQCT Calibration
The reference HR-pQCT data was captured using an665
XTremeCT4 scanner at 70 kV with a pixel sizing of 0.082×
4Scanco Medical AG Switzerland
13
0.082×0.082 mm3. No calibration phantoms were included
in this dataset, so an alternative calibration method had
to be used. The manufacturer did provide a linear cali-
bration curve based upon the scan settings. However due670
to the expected non-linearities in the HU to BMD rela-
tionship, this was not used directly. Instead, it was com-
bined with paired HR-pQCT and QCT values extracted
from the scans to generate a quadratic calibration curve.
Specifically, the manufacturers linear HR-pQCT calibra-675
tion curve and the linear QCT calibration curve were used
to fabricate paired HR-pQCT and QCT HU values over
the BMD 0−200 mg/cm3 range defined by the QRM-BCD
phantom. In addition, paired HR-pQCT and QCT image
values were extracted from corresponding profiles across680
each image pair. In each case two values were recorded:
the median low, and the median high value. The me-
dian low value is the median of the first twenty percent
of the profile, which should lie entirely in the surrounding
saline solution. The median high value if the maximum685
of the QCT profile, and the median of the maximum val-
ues recorded across the multiple HR-pQCT profiles. The
profiles were then filtered to remove all profiles where the
cortical thickness was measured to be less than 3 mm, as
image blur might start effecting the measured QCT high690
median value in these cases, or where the cortex overlaps
the portion of the profile used to generate the low median
estimates. The remaining pairs were then combined with
the fabricated data pairs before a quadratic regression line
was fit as shown in Figure A.13B. This was combined with695
the linear QCT calibration curve to give a cubic HR-pQCT
calibration curve. A representative curve is shown in Fig-
ure A.13C.
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Figure A.13: (A) The linear calibration applied to QCT scans to convert QCT HU units into BMD values. (B) The quadratic calibration
curve and the data from which this was generated, used to convert HR-pQCT HU into QCT HU units. (C) The complete quadratic calibration
curve applied to HR-pQCT scans to convert HR-pQCT HU units into BMD values.
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